![Roger Mills](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Roger Mills
Directeur Technique/Scientifique/R&D chez
ADDEX THERAPEUTICS LTD
Fortune : 39 362 $ au 30/06/2026
Profil
Dr. Roger G.
Mills, MD, is a Non-Executive Director & Chief Medical Officer at Addex Therapeutics Ltd. and a Director & Executive Vice President at San Diego Opera.
He is on the Board of Directors at Enterin, Inc., Addex Therapeutics Ltd. and San Diego Opera.
Dr. Mills was previously employed as a Chief Medical Officer & Executive VP-Development by ACADIA Pharmaceuticals, Inc., a Principal by Gilead Sciences, Inc., a Vice President-Development by Pfizer (St. Louis), and a Principal by Wellcome Foundation Ltd. He received his doctorate degree from Charing Cross Hospital Medical School.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
ADDEX THERAPEUTICS LTD 0,36 % | 18/03/2026 | 785 976 ( 0,36 % ) | 39 362 $ | 30/06/2026 |
Postes actifs de Roger Mills
| Sociétés | Poste | Début |
|---|---|---|
| ADDEX THERAPEUTICS LTD | Directeur Technique/Scientifique/R&D | 28/11/2016 |
San Diego Opera
 San Diego Opera Movies/EntertainmentConsumer Services Operates as a opera company | Directeur/Membre du Conseil | - |
Enterin, Inc.
 Enterin, Inc. BiotechnologyHealth Technology Develops novel compounds that dysfunctional gut-brain axis in patients with neurodegenerative disease | Directeur/Membre du Conseil | 13/09/2021 |
Anciens postes connus de Roger Mills
| Sociétés | Poste | Fin |
|---|---|---|
| ACADIA PHARMACEUTICALS INC. | Directeur Technique/Scientifique/R&D | 04/11/2015 |
Pfizer (St. Louis)
 Pfizer (St. Louis) BiotechnologyHealth Technology Provides research services in prescription medicines for humans and animals | Corporate Officer/Principal | - |
Wellcome Foundation Ltd
 Wellcome Foundation Ltd Commercial Printing/FormsCommercial Services Engages in priniting activities | Corporate Officer/Principal | - |
| GILEAD SCIENCES, INC. | Corporate Officer/Principal | - |
Formation de Roger Mills
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
57
Relations au 1er degré
8
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 8 |
|---|---|
Gilead Sciences, Inc.
 Gilead Sciences, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes therapeutic products and treatments for life threatening diseases | Health Technology |
ACADIA Pharmaceuticals, Inc.
 ACADIA Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals drugs for treatment of central nervous system disorders | Health Technology |
Wellcome Foundation Ltd
Wellcome Foundation Ltd Commercial Printing/FormsCommercial Services Engages in priniting activities | Commercial Services |
Addex Therapeutics Ltd.
 Addex Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Develops and commercializes drugs | Health Technology |
Pfizer (St. Louis)
Pfizer (St. Louis) BiotechnologyHealth Technology Provides research services in prescription medicines for humans and animals | Health Technology |
San Diego Opera
San Diego Opera Movies/EntertainmentConsumer Services Operates as a opera company | Consumer Services |
Enterin, Inc.
Enterin, Inc. BiotechnologyHealth Technology Develops novel compounds that dysfunctional gut-brain axis in patients with neurodegenerative disease | Health Technology |
Charing Cross Hospital Medical School
 Charing Cross Hospital Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
